Know iMCD Logo Idiopathic multicentric
Castleman disease (iMCD)
Icon of mail envelope with mail Stay Updated
For US Healthcare Professionals
For Patients
KnowIMCD Idiopathic multicentric
Castleman disease (iMCD)
Image with multiple portrayed patients staggered headshot
Stay Updated
Change Their Future
Diagnose Now
See the Diagnostic Criteria

Identifying, diagnosing, and treating iMCD can help change patients’ lives

iMCD is a rare and progressive cytokine-driven disorder that can lead to other malignant disorders if untreated.1-3

HOW TO
iDENTIFY iMCD
HOW TO
DIAGNOSE iMCD
HOW TO
TREAT iMCD
HEAR FROM
iMCD PATIENTS
Sign up for more on iMCD Stay Updated

iMCD, idiopathic multicentric Castleman disease.

References: 1. Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646-1657. 2. Liu W, Cai Q, Yu T, et al. Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up. Am J Cancer Res. 2022;12(9):4227-4240. 3. Liu AY, Nabel CS, Finkelman BS, et al. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol. 2016;3(4):e163-e175.